Silvio Garattini. Show Affiliations »
Abstract
Mesh： See more » Adverse Drug Reaction Reporting SystemsCyclooxygenase Inhibitors/adverse effectsDrug ApprovalEuropeGovernment AgenciesLactones/adverse effectsSulfones/adverse effects
Substances： See more » Cyclooxygenase InhibitorsLactonesSulfonesrofecoxib
Year: 2005 PMID： 15746147 PMCID： PMC552824 DOI： 10.1136/bmj.330.7490.540
Source DB: PubMed Journal: BMJ ISSN： 0959-8138